AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal - Reuters

Reuters | Dec. 12, 2023, 7:52 p.m. | Original
AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal Reuters
Developing Asia to end 2023 on brighter note as China's economy recovers - ADB - Reuters Why are US stocks sluggish? Some blame a looming $5 trillion options expiration - Reuters.com